The msaRAT backdoor lets the Chaos ransomware gang hide command-and-control traffic inside headless Chrome or Microsoft Edge sessions. This approach makes malicious connections look like normal ...

SHANGHAI, July 24 (Reuters) - China's central bank said on Friday it would conduct overnight ‌reverse repo operations via the open market from July 29 to 31 and on August 3 to better ⁠meet short-term ...

SHANGHAI, July 24 (Reuters) - ⁠China's ⁠central bank ⁠said on Friday it would conduct overnight reverse ‌repo operations via ‌the open ⁠market ⁠from July 29 to 31 and on August 3 to better meet ...

WordPress has patched a serious core vulnerability chain known as wp2shell, and site owners are understandably focused on updating their own sites. But there’s another question worth asking: what ...

People who have type 2 diabetes have an increased amount of sugar in their blood, also called blood glucose. Increased blood sugar happens when your body’s insulin doesn’t work as well as it should.

Waaree Renewable Technologies has received a Letter of Award (LoA) from Sunsational Power Private Limited (SPPL) for the development of a 300MW/450MWp ground-mounted solar installation. Image: Waaree ...

Video foundation models can paint a beautiful frame. They are still notoriously bad at remembering it. Push the camera through a corridor in Wan 2.1 or CogVideoX and walls warp, objects morph, and ...

Multiple Scripts: Add as many custom JavaScript snippets as you want. Organized UI: Each script is managed in its own collapsible section, keeping your configuration clean and easy to navigate. Enable ...

Cybersecurity researchers have disclosed a vulnerability in Anthropic's Claude Google Chrome Extension that could have been exploited to trigger malicious prompts simply by visiting a web page. The ...

Phase 2 Study Demonstrated 73% clinical Clearance in the 200-µg Arm suggests that ~3 out of 4 treated lesions may allow patients to avoid immediate surgical intervention. PHILADELPHIA, PA / ...

A redesigned cancer immunotherapy is showing striking early results after decades of disappointment with similar drugs. Researchers engineered a more powerful CD40 agonist antibody and changed how ...